...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Comments re AHA presentation
12
BKC
Nov 16, 2019 06:32PM
6
Nov 16, 2019 07:17PM

"For the subgroup analyses on slide 19 for above and below LDL-C and HbA1c, is this based on baseline values at start of study or values at end of study

Similar question for the eGFR<60 vs. eGFR>60. eGFR at baseline or end of study?"

Beginning of study. Testing hypotheses that certain groups (of presumably sicker) patients at the start of the trial will benefit more from the drug. 

Agree that the LDL result is puzzling.

Jupe

3
Nov 16, 2019 11:04PM
4
Nov 16, 2019 11:17PM
Share
New Message
Please login to post a reply